The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations
Open accessAbstract
Advances in clinical and translational researchOpportunities and challenges in identification of new treatment modalities for uterine fibroid therapy Pregnancy loss and uterine fibroids Stem cell origin of fibroids and effects of resveratrol Clinical advances in the treatment of uterine fibroids † Clinical management and therapeutic options Medical treatment options for women with symptomatic uterine fibroids Uterine fibroid surgical therapy † Conclusions † Future Recommendations † Charting the course-summary of breakout workgroup recommendations background: Uterine fibroids are the most common gynecologic tumors in women of reproductive age yet the etiology and pathogenesis of these lesions remain poorly understood.Age, African ancestry, nulliparity and obesity have been identified as predisposing factors for uterine fibroids.Symptomatic tumors can cause excessive uterine bleeding, bladder dysfunction and pelvic pain, as well as associated reproductive disorders such as infertility, miscarriage and other adverse pregnancy outcomes.Currently, there are limited noninvasive therapies for fibroids and no early intervention or prevention strategies are readily available.This review summarizes the advances in basic, applied and translational uterine fibroid research, in addition to current and proposed approaches to clinical management as presented at the 'Advances in Uterine Leiomyoma Research: 3rd NIH International Congress'.Congress recommendations and a review of the fibroid literature are also reported.methods: This review is a report of meeting proceedings, the resulting recommendations and a literature review of the subject. results:The research data presented highlights the complexity of uterine fibroids and the convergence of ethnicity, race, genetics, epigenetics and environmental factors, including lifestyle and possible socioeconomic parameters on disease manifestation.The data presented suggest it is likely that the majority of women with uterine fibroids will have normal pregnancy outcomes; however, additional research is warranted.As an alternative to surgery, an effective long-term medical treatment for uterine fibroids should reduce heavy uterine bleeding and fibroid/uterine volume without excessive side effects.This goal has not been achieved and current treatments reduce symptoms only temporarily; however, a multi-disciplined approach to understanding the molecular origins and pathogenesis of uterine fibroids, as presented in this report, makes our quest for identifying novel targets for noninvasive, possibly nonsystemic and effective long-term treatment very promising.conclusions: The Congress facilitated the exchange of scientific information among members of the uterine leiomyoma research and health-care communities.While advances in research have deepened our knowledge of the pathobiology of fibroids, their etiology still remains incompletely understood.Further needs exist for determination of risk factors and initiation of preventive measures for fibroids, in addition to continued development of new medical and minimally invasive options for treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0001 · Cited by 310
Aromatase in endometriosis and uterine leiomyomata
Bulun, S. E., Imir, G., Utsunomiya, H., Thung, S., Gurates, B., Tamura, M., & Lin, Z. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.012 · Cited by 154 · cited 1×
“, 2013), aromatase inhibitors (Bulun et al., 2005), cyclin-dependent kinase (CDK) inhibitors (Shime et al.”
BackgroundRole of stem cells in human uterine leiomyoma growth
Ono, M., Qiang, W., Serna, V. A., Yin, P., Coon, J. S., Navarro, A., Monsivais, D., Kakinuma, T., Dyson, M., Druschitz, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036935 · Cited by 141
Mas, A., Cervelló, I., Gil-Sanchis, C., Faus, A., Ferro, J., Pellicer, A., & Simón, C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.044 · Cited by 104 · cited 3×
“Studies have shown that within the uterus there is a SP of stem cells that is multipotent (Flake et al., 2003; Walker and Stewart, 2005; Ono et al., 2007, 2012; Ciarmela et al., 2011; Mas et al., 2012).”
BackgroundThe association between self-reported major life events and the presence of uterine fibroids
Vines, A. I., Ta, M., & Esserman, D. A. (2010) · Women's Health Issues · doi:10.1016/j.whi.2010.03.009 · Cited by 67
Cited by
Uterine fibroid management: From the present to the future
Donnez, J., & Dolmans, M.-M. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw023 · Cited by 780
Epidemiology and management of uterine fibroids
Giuliani, E., As‐Sanie, S., & Marsh, E. E. (2020) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.13102 · Cited by 674
Prospective Cohort Study of Uterine Fibroids and Miscarriage Risk
Hartmann, K. E., Velez Edwards, D. R., Savitz, D. A., Jonsson-Funk, M. L., Wu, P., Sundermann, A. C., & Baird, D. D. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx062 · Cited by 51
Metadata
- Authors
- Segars, J. H., Parrott, E. C., Nagel, J. D., Guo, X. C., Gao, X., Birnbaum, L. S., Pinn, V. W., & Dixon, D.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-08
- Volume
- 20
- Issue
- 3
- Pages
- 309-333
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2169959327
- Cited by
- 186
- References
- 5
- FWCI
- 20.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. https://app.cochat.ai/papers/10.1093/humupd/dmt058
- The paper
- Segars, J. H., Parrott, E. C., Nagel, J. D., Guo, X. C., Gao, X., Birnbaum, L. S., Pinn, V. W., & Dixon, D. (2014). Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Human Reproduction Update. https://doi.org/10.1093/humupd/dmt058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.